Daniel Joseph McCarthy - 22 Aug 2024 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
PRESIDENT
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Issuer symbol
EVH
Transactions as of
22 Aug 2024
Net transactions value
-$958,186
Form type
4
Filing time
26 Aug 2024, 20:16:38 UTC
Previous filing
05 Mar 2024
Next filing
04 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Options Exercise $112,612 +4,550 +2.1% $24.75 222,502 22 Aug 2024 Direct F1, F2
transaction EVH Class A Common Stock Sale $500,790 -16,693 -7.5% $30.00 205,809 22 Aug 2024 Direct F1, F2
transaction EVH Class A Common Stock Sale $231,000 -7,000 -3.4% $33.00 198,809 22 Aug 2024 Direct F1, F2
transaction EVH Class A Common Stock Sale $207,008 -6,469 -3.3% $32.00 192,340 23 Aug 2024 Direct F1, F2
transaction EVH Class A Common Stock Sale $132,000 -4,000 -2.1% $33.00 188,340 23 Aug 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVH Class A Common Stock Option (right to buy) Options Exercise $0 -4,550 -100% $0.000000 0 22 Aug 2024 Class A Common Stock 4,550 $24.75 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2024.
F2 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F3 The Class A Common Stock Options exercised vested on August 1, 2018, August 1, 2019, August 1, 2020, and August 1, 2021.